Assisted reproductive technique outcomes in hypogonadotropic hypogonadism women
Firouzeh Ghaffari, Arezoo Arabipoor, Narqes Bagheri Lankarani and 2 more
Annals of Saudi Medicine · 2013
doi:10.5144/0256-4947.2013.235 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
BACKGROUND AND OBJECTIVES: To evaluate the outcomes of using in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI cycle) techniques in hypogonadotropic hypogonadism (HH) women and comparing them to women with tubal factor infertility. DESIGN AND SETTINGS: Retrospective cohort study in Royan Institute, Iran. PATIENTS AND METHODS: Data from 81 HH patients treated with IVF/ICSI in the period from early 2009 until the end of 2010 were analyzed and compared with treatment results from 89 patients with tubal factor infertility. Moreover, data from the HH patients were analyzed with respect to the age factor. P value <.05 was considered statistically significant. The main outcome measures were implantation, fertilization, pregnancy, and live birth rates. RESULTS: Despite a higher fertilization rate and higher number of grade A/B embryos transferred in the tubal factor group, the implantation, pregnancy, and live birth rates were found to be similar between the 2 groups (P=.3, P=.1, P=.1, respectively). When the HH patients were evaluated according to the age factor, no significant difference was found regarding outcome parameters (P=.2). CONCLUSIONS: HH women that were treated with IVF/ICSI cycles seem to have a sound potential for pregnancy, even in advanced age patients.
Abstract licence: CC BY-NC-ND
References14
14 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.